Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2003 Jul;163(1):368; author reply 368-9.
doi: 10.1016/s0002-9440(10)63661-9.

The function of COX-2 in human ovarian carcinoma

Roshan Agarwal
Comment

The function of COX-2 in human ovarian carcinoma

Roshan Agarwal. Am J Pathol. 2003 Jul.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Univariate survival analysis (Kaplan-Meier) of 47 patients with ovarian carcinoma treated with a platinum-based chemotherapy: the median survival of patients with tumors positive for COX-2 was reduced compared to patients with tumors negative for COX-2 (log rank test, P = 0.03).
See this image and copyright information in PMC

Comment on

Similar articles

See all similar articles

References

    1. Denkert C, Köbel M, Pest S, Koch I, Berger S, Schwabe M, Siegert S, Reles A, Klosterhalfen B, Hauptmann S: Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. Am J Pathol 2002, 160:893-903 - PMC - PubMed
    1. Hoskins WJ, Bundy BN, Thigpen JT, Omura GA: The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a gynecologic oncology group study. Gynecol Oncol 1992, 47:159-166 - PubMed
    1. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002, 20:1248-1259 - PubMed
    1. Bertelsen K: Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study. Gynecol Oncol 1990, 38:203-209 - PubMed
    1. Piver MS, Lele SB, Marchetti DL, Baker TR, Tsukada Y, Emrich LJ: The impact of aggressive de-bulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma. J Clin Oncol 1988, 6:983-989 - PubMed